Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
XZB-0004
DRUG
2 trials
Sponsors
Xuanzhu Biopharmaceutical Co., Ltd.
Conditions
AML
Advanced Solid Tumor
MDS
NSCLC
Phase 1
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
NCT05740917
Xuanzhu Biopharmaceutical Co., Ltd.
AML, MDS
Start: 2023-02-28
End: 2023-02-28
Target: 82
Updated: 2023-02-23
A Study of XZB-0004 in Patients With Solid Tumors
Recruiting
NCT05772455
Xuanzhu Biopharmaceutical Co., Ltd.
Advanced Solid Tumor, NSCLC
Start: 2023-03-24
End: 2027-02-28
Target: 128
Updated: 2024-10-28